Used in research and development of diagnostics and therapeutics for Alzheimer’s disease. Binds specifically to amyloid-beta peptides, helping to detect and quantify plaque formation in brain tissue and biological fluids. Employed in immunoassays, immunohistochemistry, and ELISA-based methods to study amyloid pathology. Supports target validation and monitoring of treatment efficacy in preclinical models. Also utilized as a control antibody in comparative studies with therapeutic antibodies targeting amyloid-beta.